Evaluation of SCOUT DS in Subjects With Type 2 Diabetes #2

VeraLight, Inc.264 enrolled

Overview

The primary objective of the trial is to collect SCOUT DS and Hemoglobin A1c measurements of subjects who have been diagnosed with Type 2 diabetes.

Previous studies have excluded subjects with Type 2 diabetes. The primary objective of this study is to correct an imbalance in the disease prevalence of the data set used to develop the SCOUT DS diabetes screening algorithm.

Study Type

OBSERVATIONAL

Enrollment

264

Conditions

Diabetes Mellitus, Non-Insulin Dependent

Eligibility

Sex: ALLMin age: 18 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Age greater than or equal to 18 years Self-reported diagnosis of type 2 diabetes No Self-reported diagnosis of type 2 diabetes Exclusion Criteria: * Less than 18 years of age * Diagnosed with type 1 diabetes * Known to be pregnant (Self Reported) * Receiving dialysis or having known renal compromise * Scars, tattoos, rashes or other disruption/discoloration on the left volar forearm. * Known to have, or at risk for, photosensitivity reactions ( e.g., sensitive to ultraviolet light, or taking medication known to cause photosensitivity)

Locations (1)

Albuquerque Convention Center

Albuquerque, New Mexico, United States

Outcomes

Primary Outcomes

Continuing validation of SCOUT DS algorithm

Collect SCOUT DS and Hemoglobin A1c measurements of subjects with Type 2 Diabetes

Time frame: 1 day

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.